Objective The liver is regularly exposed to changing metabolic and inflammatory environments.
It must sense and adapt to metabolic need while balancing resources required to protect …

Lack of preclinical model translation is often blamed for failed drug development. Here we
discuss mouse models within the context of human steatotic liver disease (SLD). Variables …

Nonalcoholic fatty liver disease (NAFLD) is a growing epidemic linked to metabolic disease.
The first stage of NAFLD is characterized by lipid accumulation in hepatocytes, but this can …

We identify biomarkers for disease progression in three type 2 diabetes cohorts encompassing
2,973 individuals across three molecular classes, metabolites, lipids and proteins. …

<p>Many people living with diabetes also have nonalcoholic fatty liver disease (NAFLD).
Interleukin-6 (IL-6) is involved in both diseases, interacting with both membrane-bound (…

Hepatocellular carcinoma (HCC) is strongly associated with metabolic dysregulations/deregulations
and hyperglycemia is a common metabolic disturbance in metabolic diseases. …

Background Considerable evidence suggests that oxidative stress plays an essential role in
the progression of hepatocellular carcinoma (HCC). While acquired resistance to oxidative …

The role of heparin as an anticoagulant is well defined; however, its role in tumorigenesis and
tumor progression is not clear yet. Some studies have shown that anticoagulant treatment …

Hepatocellular carcinoma (HCC) is a major health problem worldwide and most cases are
incurable because of late presentation. It is the most common primary neoplasm of the liver …

Heparins play an important role in cell growth, differentiation, migration and invasion. However,
the molecular mechanisms of heparin mediated cellular behaviors are not well defined. …